Evaxion A (EVAX) Receivables (2019 - 2023)
Evaxion A (EVAX) reported Receivables of $2.1 million for Q4 2023, down 26.45% on a YoY basis from $2.8 million in Q4 2022, and down 26.45% quarter-over-quarter from $2.8 million in Q4 2022.
Evaxion A (EVAX) Receivables (2019 - 2023) Analysis & Trends
Evaxion A has reported Receivables for 5 years, with the latest figure at $2.1 million in Q4 2023.
- For the quarter ending Q4 2023, Receivables fell 26.45% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2023 stood at $2.1 million (down 26.45% YoY), and the FY2023 full-year result was $2.1 million, down 26.45% from the prior year.
- Receivables for Q4 2023 stood at $2.1 million, down from $2.8 million in the prior quarter.
- The five-year high for Receivables was $2.8 million in Q4 2022, with the low at $607000.0 in Q4 2019.
- Historically, Receivables has averaged $1.7 million across 5 years, with a median of $1.6 million in 2020.
- Annual changes were most pronounced in 2020 — Receivables jumped 157.0% — and 2023, when it dropped 26.45%.
- Evaxion A's Receivables stood at $607000.0 in 2019, then jumped by 157.0% to $1.6 million in 2020, then declined by 19.81% to $1.3 million in 2021, then surged by 123.9% to $2.8 million in 2022, then declined by 26.45% to $2.1 million in 2023.
- The last three Receivables figures came in at $2.1 million (Q4 2023), $2.8 million (Q4 2022), and $1.3 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 5.73 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 1.25 Mn |
| Dec 31, 2020 | 1.56 Mn |
| Dec 31, 2019 | 607,000.00 |